Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension

Hypertension is particularly prevalent in patients aged ⩾65 years, those with a body mass index ⩾30 kg m(−2), Blacks and those with type II diabetes. Here we report a prespecified secondary analysis of the efficacy of amlodipine (10 mg day(−1)), olmesartan medoxomil (40 mg day(−1)), a combination of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Chrysant, S G, Lee, J, Melino, M, Karki, S, Heyrman, R
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2010
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2963900/
https://ncbi.nlm.nih.gov/pubmed/20164847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jhh.2010.5
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia